TrialJournal of acquired immune deficiency syndromes (1999)2018

Viral Drug Resistance Through 48 Weeks, in a Phase 2b, Randomized, Controlled Trial of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir.

Max Lataillade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.